FAAH and nasopharyngeal carcinoma: We also extend this concept to another sphingolipid storage disease, NPC, by showing CB1 receptor downregulation in a mouse model and a patient and that FAAH inhibition reduces SM and cholesterol levels in NPC patient‐derived cells and in the brain of a NPC mouse model.